MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luo, Z. D.
Right arrow Articles by Taylor, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luo, Z. D.
Right arrow Articles by Taylor, P.

Vol. 56, Issue 5, 886-894, November 1999

Calcineurin Enhances Acetylcholinesterase mRNA Stability during C2-C12 Muscle Cell Differentiation

Z. David Luo, Yibin Wang, Guy Werlen,1 Shelley Camp, Kenneth R. Chien, and Palmer Taylor

Departments of Pharmacology (Z.D.L., G.W., S.C., P.T.) and Medicine (Y.W., K.R.C.), University of California-San Diego, La Jolla, California

Treatment of C2-C12 mouse myoblasts with the immunosuppressant drug cyclosporin A (CsA) enhances the increase in acetylcholinesterase (AChE) expression observed during skeletal muscle differentiation. The enhanced AChE expression is due primarily to increased mRNA stability because CsA treatment increases the half-life of AChE mRNA, but not the apparent transcriptional rate of the gene. Neither tacrolimus (FK506), an immunosuppressive agent with a distinct structure, nor cyclosporine H, an inactive congener of CsA, alters AChE expression. The enhanced AChE expression is associated with the muscle differentiation process, but cannot be triggered by CsA exposure before differentiation. Myoblasts and myotubes of C2-C12 cells express similar amounts of cyclophilin A and FKBP12, immunophilins known to be intracellular-binding targets for CsA and tacrolimus, respectively. However, cellular levels of calcineurin, a calcium/calmodulin-dependent phosphatase known to be the cellular target of ligand-immunophilin complexes, increase 3-fold during myogenesis. Overexpression of constitutively active calcineurin in differentiating cells reduces AChE mRNA levels and CsA antagonizes such an inhibition. Conversely, overexpression of a dominant negative calcineurin construct increases AChE mRNA levels, which are further enhanced by CsA. Thus, a CsA sensitive, calcineurin mediated pathway appears linked to differentiation-induced stabilization of AChE mRNA during myogenesis.

Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
J. V. Chakkalakal, P. Miura, G. Belanger, R. N. Michel, and B. J. Jasmin
Modulation of utrophin A mRNA stability in fast versus slow muscles via an AU-rich element and calcineurin signaling
Nucleic Acids Res., February 11, 2008; 36(3): 826 - 838.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
X. Mu, L. D. Brown, Y. Liu, and M. F. Schneider
Roles of the calcineurin and CaMK signaling pathways in fast-to-slow fiber type transformation of cultured adult mouse skeletal muscle fibers
Physiol Genomics, August 20, 2007; 30(3): 300 - 312.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. Pregelj, M. Trinkaus, D. Zupan, J. J. Trontelj, and J. Sketelj
The Role of Muscle Activation Pattern and Calcineurin in Acetylcholinesterase Regulation in Rat Skeletal Muscles
J. Neurosci., January 31, 2007; 27(5): 1106 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Deschenes-Furry, K. Mousavi, F. Bolognani, R. L. Neve, R. J. Parks, N. I. Perrone-Bizzozero, and B. J. Jasmin
The RNA-Binding Protein HuD Binds Acetylcholinesterase mRNA in Neurons and Regulates its Expression after Axotomy
J. Neurosci., January 17, 2007; 27(3): 665 - 675.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Sun, H. C. Blair, Y. Peng, N. Zaidi, O. A. Adebanjo, X. B. Wu, X. Y. Wu, J. Iqbal, S. Epstein, E. Abe, et al.
Calcineurin regulates bone formation by the osteoblast
PNAS, November 22, 2005; 102(47): 17130 - 17135.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
E. K. K. Tung, R. C. Y. Choi, N. L. Siow, J. X. S. Jiang, K. K. Y. Ling, J. Simon, E. A. Barnard, and K. W. K. Tsim
P2Y2 Receptor Activation Regulates the Expression of Acetylcholinesterase and Acetylcholine Receptor Genes at Vertebrate Neuromuscular Junctions
Mol. Pharmacol., October 1, 2004; 66(4): 794 - 806.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. H. C. Lee, R. C. Y. Choi, A. K. L. Ting, N. L. Siow, J. X. S. Jiang, J. Massoulie, and K. W. K. Tsim
Transcriptional Regulation of Acetylcholinesterase-associated Collagen ColQ: DIFFERENTIAL EXPRESSION IN FAST AND SLOW TWITCH MUSCLE FIBERS IS DRIVEN BY DISTINCT PROMOTERS
J. Biol. Chem., June 25, 2004; 279(26): 27098 - 27107.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. A. Parsons, D. P. Millay, B. J. Wilkins, O. F. Bueno, G. L. Tsika, J. R. Neilson, C. M. Liberatore, K. E. Yutzey, G. R. Crabtree, R. W. Tsika, et al.
Genetic Loss of Calcineurin Blocks Mechanical Overload-induced Skeletal Muscle Fiber Type Switching but Not Hypertrophy
J. Biol. Chem., June 18, 2004; 279(25): 26192 - 26200.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Deschenes-Furry, G. Belanger, N. Perrone-Bizzozero, and B. J. Jasmin
Post-transcriptional Regulation of Acetylcholinesterase mRNAs in Nerve Growth Factor-treated PC12 Cells by the RNA-binding Protein HuD
J. Biol. Chem., February 14, 2003; 278(8): 5710 - 5717.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Sanna, D. Kramer, and A. A. Genazzani
The Expression of the PDZ Protein MALS-1/Velis Is Regulated by Calcium and Calcineurin in Cerebellar Granule Cells
J. Biol. Chem., December 13, 2002; 277(51): 49585 - 49590.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
E. Meshorer, C. Erb, R. Gazit, L. Pavlovsky, D. Kaufer, A. Friedman, D. Glick, N. Ben-Arie, and H. Soreq
Alternative Splicing and Neuritic mRNA Translocation Under Long-Term Neuronal Hypersensitivity
Science, January 18, 2002; 295(5554): 508 - 512.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
A. O. Gramolini, G. Belanger, J. M. Thompson, J. V. Chakkalakal, and B. J. Jasmin
Increased expression of utrophin in a slow vs. a fast muscle involves posttranscriptional events
Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1300 - C1309.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
B. B. Friday, V. Horsley, and G. K. Pavlath
Calcineurin Activity Is Required for the Initiation of Skeletal Muscle Differentiation
J. Cell Biol., May 1, 2000; 149(3): 657 - 666.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. M. Angus, R. Y. Y. Chan, and B. J. Jasmin
Role of Intronic E- and N-box Motifs in the Transcriptional Induction of the Acetylcholinesterase Gene during Myogenic Differentiation
J. Biol. Chem., May 11, 2001; 276(20): 17603 - 17609.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics